QuidelOrtho Corporation (QDEL) Stock

QuidelOrtho Corporation (QDEL) is a Healthcare stock trading at $13.67 (as of 2026-06-18), with a market capitalization of $887.85M and a trailing P/E of -0.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

QuidelOrtho Corporation develops and manufactures diagnostic testing technologies used across healthcare testing needs. Its main business activities include laboratory diagnostics (including clinical chemistry and immunoassays), transfusion medicine testing for blood compatibility and donor screening, point-of-care tests for rapid results, and molecular diagnostics.

Valuation — source: SEC EDGAR (first-party)
Price$13.67
Market Cap$887.85M
P/E Ratio-0.7
EV / EBITDA-6.9
Price / Book0.48
Price / Sales0.34
DCF Value (model)$-60.50
DCF Upside vs Price-542.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$2.73B
Net Margin-41.5%
Return on Equity-65.4%
Debt / Equity1.58
Current Ratio1.43
Revenue Growth (YoY)-1.9%
EPS Growth (YoY)-45.4%
FCF Growth (YoY)-26.0%
Financial Health — source: SEC EDGAR
Altman Z-Score-0.10 (distress)
Valuation vs Sector & Industry
Stock P/E-0.7
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-103.5%
vs Industry-104.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderCarlyle Group Inc. ($376.66M)
Institutional Holders Tracked10
Congressional Trades (recent)1
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOBrian J. Blaser
Employees6,600
CountryUS
IPO Date1991-02-01

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • GRAIL, Inc. (GRAL)
  • Celldex Therapeutics, Inc. (CLDX)
  • BillionToOne, Inc. (BLLN)
  • Fortrea Holdings Inc. (FTRE)
  • Anbio Biotechnology Class A Ordinary Shares (NNNN)
  • Neogen Corporation (NEOG)
  • Castle Biosciences, Inc. (CSTL)
  • CareDx, Inc (CDNA)
QDEL earnings history · QDEL institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.